Shafaat Ali Choyon.

Essay · Artificial Intelligence

After the scribe: where health AI goes next

By Md Shafaat Ali Choyon MPH · CHES® · MBA · MCIM · builds & runs AI in production · Growth & health strategist · 6 min read ·

The AI scribe got all the attention, but it was the easy win, a narrow, low-stakes task with a clean before-and-after. The interesting question for 2026 isn't how well AI writes the clinical note. It's what AI does *after* documentation is solved, in the parts of healthcare nobody makes demos about.

After the scribe, the next health-AI wave runs the clinic around the note; scheduling, prior auth, revenue cycle, referrals.
The next frontier, at a glance, click to enlarge.

Where does health AI go after the medical scribe?

Ambient documentation was a great first act because it's contained: one task, one obvious pain, low risk if a human reviews it. That's exactly why it scaled first. But it's also why it's not the prize. The note was never where the cost and the burnout concentrated, that's the back office.

The back office is where the money and the misery are

Scheduling, prior authorization, referrals, revenue cycle, denials, inventory, the unglamorous operational load that quietly consumes clinician hours and clinic margins. In the US, administrative work is a notorious share of total health spending. That's the frontier: not writing the note faster, but running the machine around the note better. It's a harder, messier problem than documentation, which is precisely why it's the valuable one.

I've digitized the back office by hand

I know this layer because I rebuilt it without AI, the slow way. As COO digitizing a multi-entity clinical group at Laser Treat, the wins came from integrating systems and fixing process, and they showed up as +13% patient retention and roughly −$0.5M in operating cost. Nothing about that work would have demoed well. AI doesn't replace that job; it accelerates exactly it, the integration, the triage of routine operational decisions, the measurement, which is why the next wave of health AI will be operational, not clinical.

The scribe writes the note. The next wave runs the clinic around it.

The dual-market shape

In the US, the opportunity is deflating an enormous administrative cost base. In Bangladesh, where operations are leaner but capacity is brutally constrained, AI in the back office is a force multiplier, it lets a small team run a service that would otherwise need a big one. Same tools, two jobs: cutting waste in one market, creating capacity in the other.

The short version

In your organization, is AI aimed at the visible task, or at the invisible back office that actually drains the time and money?

Frequently asked questions

What comes after the AI medical scribe in health AI?

The scribe automated documentation, a contained, low-risk task, which is exactly why it scaled first. The next wave of health AI moves into the back office: scheduling, prior authorization, referrals, revenue cycle, and denials, the unglamorous operational load that actually drains clinician hours and clinic margins.

Why is the healthcare back office harder to fix than the clinical note?

It's messier and less demo-friendly than a single scribe task, but it's where the real cost and burnout concentrate. I rebuilt this layer by hand at Laser Treat, without AI, through system integration and process fixes, and AI accelerates exactly that kind of work rather than replacing it.

What results came from fixing the back office by hand at Laser Treat?

As COO digitizing a multi-entity clinical group, integrating systems and fixing process produced +13% patient retention and roughly −$0.5M in operating cost, purely from operational discipline, before any AI was involved.

Md Shafaat Ali Choyon (MPH, CHES®, MBA, MCIM) is a growth, marketing and public-health strategist who builds and runs AI in production, with 17 years across telecom, fintech, e-commerce, consumer tech and healthcare in the US and Bangladesh. See the essays or the portfolio.

Get new essays by email

New pieces on AI in production, growth, and public health — occasional, no spam, unsubscribe anytime.

Same list as HSREP — you’ll get the essays and the occasional research note.